➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Baxter
Mallinckrodt
Medtronic
Moodys

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED AND INACTIVATED POLIOVIRUS VACCINE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00707148 Pertussis Vaccine in Healthy Pregnant Women Completed National Institute of Allergy and Infectious Diseases (NIAID) Phase 1 2009-01-01 The purpose of this study is to look at the safety and immunogenicity of a combination vaccine that includes tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap). The study will be conducted in 48 pregnant women and 32 non-pregnant women. Safety of the newborn infant and the effect of the mother's vaccination on the infants' immune responses prior to vaccinating infants with another combination vaccine to protect against diphtheria, tetanus, and pertussis will be evaluated. Participants will be 18-45 years old. Pregnant volunteers will be 30-32 weeks pregnant and at a low risk for pregnancy complications. Pregnant volunteers will receive 2 injections (1 vaccine and 1 placebo, inactive substance); non-pregnant volunteers will receive 1 injection of vaccine. Blood samples will be collected from the mother and infant, along with the baby's growth measurements. Participation for mother infant pairs is about 15 months and about 7 months for non-pregnant women.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine

Condition Name

Condition Name for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
Intervention Trials
Tetanus 1
Pertussis 1
Diphtheria 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
Intervention Trials
Whooping Cough 1
Tetanus 1
Diphtheria 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine

Trials by Country

Trials by Country for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
Location Trials
United States 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
Location Trials
Washington 1
Texas 1
North Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine

Clinical Trial Phase

Clinical Trial Phase for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
Clinical Trial Phase Trials
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine

Sponsor Name

Sponsor Name for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
Sponsor Trials
National Institute of Allergy and Infectious Diseases (NIAID) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine
Sponsor Trials
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Harvard Business School
Colorcon
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.